CD79A and Cirrhosis: 18.4% of patients with Child C cirrhosis were triple-positive for ASCA IgA, ASCA IgG, and anti-OMP PlusTM IgA antibodies, compared with only 4.2% in Child A and 10.3% in Child B groups (p<0.01 for both).